On October 2, 2020 India and South Africa proposed a temporary waiver on coronavirus vaccine patent rights in a meeting of the World Trade Organization. With over 100 co-signatories (mostly developing countries), the so-called “TRIPS Vaccine Waiver” has raised questions about intellectual property and access ethics during a pandemic.Continue Reading